metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet
RxNorm concept 2709491, clinical drug (scd). Prescribable name: metFORMIN hydrochloride 500 MG / SITagliptin phosphate 50 MG Oral Tablet.
- RxCUI
- 2709491
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2709491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
metFORMIN hydrochloride 500 MG / SITagliptin phosphate 50 MG Oral Tablet
Related concepts
- metformin hydrochloride 500 MG (SCDC, consists of)
- sitagliptin phosphate 50 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet [Janumet] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2709491 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2709491 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2709491. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.